These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 22306692)

  • 41. Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells.
    Montealegre S; van Endert PM
    Front Immunol; 2018; 9():3098. PubMed ID: 30666258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heat shock proteins in antigen trafficking--implications on antigen presentation to T cells.
    Udono H; Ichiyanagi T; Mizukami S; Imai T
    Int J Hyperthermia; 2009 Dec; 25(8):617-25. PubMed ID: 19551545
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autophagy and MHC-restricted antigen presentation.
    Valečka J; Almeida CR; Su B; Pierre P; Gatti E
    Mol Immunol; 2018 Jul; 99():163-170. PubMed ID: 29787980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I.
    Horrevorts SK; Duinkerken S; Bloem K; Secades P; Kalay H; Musters RJ; van Vliet SJ; García-Vallejo JJ; van Kooyk Y
    Front Immunol; 2018; 9():1231. PubMed ID: 29963041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of the TAP-like transporter in antigen presentation and phagosome maturation.
    Lawand M; Evnouchidou I; Baranek T; Montealegre S; Tao S; Drexler I; Saveanu L; Si-Tahar M; van Endert P
    Mol Immunol; 2019 Sep; 113():75-86. PubMed ID: 29941219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2.
    Zuo J; Thomas WA; Haigh TA; Fitzsimmons L; Long HM; Hislop AD; Taylor GS; Rowe M
    PLoS Pathog; 2011 Dec; 7(12):e1002455. PubMed ID: 22216005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intracellular recycling and cross-presentation by MHC class I molecules.
    van Endert P
    Immunol Rev; 2016 Jul; 272(1):80-96. PubMed ID: 27319344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment.
    Dani A; Chaudhry A; Mukherjee P; Rajagopal D; Bhatia S; George A; Bal V; Rath S; Mayor S
    J Cell Sci; 2004 Aug; 117(Pt 18):4219-30. PubMed ID: 15316082
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carbon monoxide decreases endosome-lysosome fusion and inhibits soluble antigen presentation by dendritic cells to T cells.
    Tardif V; Riquelme SA; Remy S; Carreño LJ; Cortés CM; Simon T; Hill M; Louvet C; Riedel CA; Blancou P; Bach JM; Chauveau C; Bueno SM; Anegon I; Kalergis AM
    Eur J Immunol; 2013 Nov; 43(11):2832-44. PubMed ID: 23852701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HIV-Infected Dendritic Cells Present Endogenous MHC Class II-Restricted Antigens to HIV-Specific CD4+ T Cells.
    Coulon PG; Richetta C; Rouers A; Blanchet FP; Urrutia A; Guerbois M; Piguet V; Theodorou I; Bet A; Schwartz O; Tangy F; Graff-Dubois S; Cardinaud S; Moris A
    J Immunol; 2016 Jul; 197(2):517-32. PubMed ID: 27288536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ii-Key/HER-2/neu(776-790) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/neu+ tumors.
    Sotiriadou NN; Kallinteris NL; Gritzapis AD; Voutsas IF; Papamichail M; von Hofe E; Humphreys RE; Pavlis T; Perez SA; Baxevanis CN
    Cancer Immunol Immunother; 2007 May; 56(5):601-13. PubMed ID: 16960693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain.
    Faure-André G; Vargas P; Yuseff MI; Heuzé M; Diaz J; Lankar D; Steri V; Manry J; Hugues S; Vascotto F; Boulanger J; Raposo G; Bono MR; Rosemblatt M; Piel M; Lennon-Duménil AM
    Science; 2008 Dec; 322(5908):1705-10. PubMed ID: 19074353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II.
    SenGupta D; Norris PJ; Suscovich TJ; Hassan-Zahraee M; Moffett HF; Trocha A; Draenert R; Goulder PJ; Binder RJ; Levey DL; Walker BD; Srivastava PK; Brander C
    J Immunol; 2004 Aug; 173(3):1987-93. PubMed ID: 15265933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The biological function and significance of CD74 in immune diseases.
    Su H; Na N; Zhang X; Zhao Y
    Inflamm Res; 2017 Mar; 66(3):209-216. PubMed ID: 27752708
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery.
    Schnurr M; Chen Q; Shin A; Chen W; Toy T; Jenderek C; Green S; Miloradovic L; Drane D; Davis ID; Villadangos J; Shortman K; Maraskovsky E; Cebon J
    Blood; 2005 Mar; 105(6):2465-72. PubMed ID: 15546948
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading.
    Robson NC; Beacock-Sharp H; Donachie AM; Mowat AM
    Immunology; 2003 Jul; 109(3):374-83. PubMed ID: 12807483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [MHC class II restricted antigen presentation].
    Hirata S; Nishimura Y
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():299-303. PubMed ID: 15861672
    [No Abstract]   [Full Text] [Related]  

  • 60. Antibody-mediated targeting of antigen to C-type lectin-like receptors Clec9A and Clec12A elicits different vaccination outcomes.
    Macri C; Dumont C; Panozza S; Lahoud MH; Caminschi I; Villadangos JA; Johnston AP; Mintern JD
    Mol Immunol; 2017 Jan; 81():143-150. PubMed ID: 27978488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.